Expert Review of Vaccines

What about cholera vaccines?
pp. 403-405(3)
Author: Chaignat, Claire-Lise

Novel method to screen for potential vaccine antigens
pp. 407-410(4)

Immortalized B cells: a neverending source of antigen-presenting cells for vaccines?
pp. 411-415(5)
Authors: Draube, Andreas; von Bergwelt-Baildon, Michael

Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses
pp. 417-429(13)
Authors: Swenson, Dana L; Warfield, Kelly L; Larsen, Tom; Alves, D Anthony; Coberley, Sadie S; Bavari, Sina

Cholera in disasters: do vaccines prompt new hopes?
pp. 431-435(5)
Authors: Chaignat, Claire-Lise; Monti, Victoria; Soepardi, Jane; Petersen, Georg; Sorensen, Eigil; Narain, Jai; Kieny, Marie Paule

Monitoring the impact of vaccines postlicensure: new challenges, new opportunities
pp. 437-456(20)
Authors: Schuchat, Anne; Bell, Beth P

Microenvironmental impact on lung cell homeostasis and immunity during infection
pp. 457-466(10)
Authors: Tournier, Jean-Nicolas; Mohamadzadeh, Mansour

Microenvironmental impact on lung cell homeostasis and immunity during infection
pp. 457-466(10)
Authors: Tournier, Jean-Nicolas; Mohamadzadeh, Mansour

Age-related decline in immunity: implications for vaccine responsiveness
pp. 467-479(13)
Authors: Kumar, Rajesh; Burns, Edith A

New drugs and vaccines for drug-resistant Mycobacterium tuberculosis infections
pp. 481-497(17)
Authors: Dover, Lynn G; Bhatt, Apoorva; Bhowruth, Veemal; Willcox, Benjamin E; Besra, Gurdyal S

Various carrier system(s)- mediated genetic vaccination strategies against malaria
pp. 499-520(22)
Authors: Tyagi, Rajeev K; Sharma, Pradeep Kumar; Vyas, Suresh P; Mehta, Abhinav

Acknowledgements
pp. 525-525(1)